Introduction
As of May 2017, there were 4242 Certified Genetic Counselors (CGC) (American Board of Genetic Counseling, Inc. 2017) and 41 graduate-level genetic counseling training programs (Accreditation Council for Genetic Counseling 2017) in North America, and the demand for CGCs continues to increase. Between 2013 and 2016 there was a 20% annual growth in NSGC job postings for CGCs, and it appeared that it was taking many months for employers to fill some open positions. The increasing number and decreasing cost of genetic tests and the expansion of genetics and genomics into mainstream medicine are likely contributing to an increase in demand for the services of CGCs. Additionally, with an increasing number of CGCs working outside of the clinical setting, such as employment in commercial laboratories, education, public health and policy, (National Society of Genetic Counselors: 2016 Professional Status Survey Executive Summary 2016 , there is additional pressure on the existing CGC workforce to meet the future demand for clinical services and in other areas of genetic service delivery.
The genetic counselor profession is committed to ensuring that there is an adequate CGC workforce to meet future demand. In 2013 the major U.S. professional genetic counseling organizations began discussions to address the state of the CGC workforce. These discussions led to the formation of the Workforce Working Group (WFWG) in 2015. The WFWG initially comprised representatives from the American Board of Genetic Counseling (ABGC), the Accreditation Council for Genetic Counseling (ACGC), the Association of Genetic Counseling Program Directors (AGCPD) and the National Society of Genetic Counselors (NSGC). The charges to the WFWG were as follows:
& Identify current and future barriers and opportunities that impact the growth of the CGC workforce. & Make recommendations to and support the development of specific action items that will facilitate growth of the profession and minimize and/or remove barriers to expansion. & Drive and coordinate the efforts of the professional genetic counseling organizations to ensure the action items recommended by the working group are carried out in the most efficient and effective manner possible.
While the profession has grown 88% since 2006 (National Society of Genetic Counselors: Genetic Counseling Industry Statistics 2016), the number of CGCs remains relatively small compared to other healthcare professions. With the trend towards an increasing number of available jobs and an unemployment rate of only 0.8% for CGCs, roughly five times lower than the national rate, it became apparent to the WFWG and leaders of the professional genetic counseling organizations that there was a shortage of CGCs compared to demand. However, the scale of the shortage was unclear, and there was a lack of data needed to inform policy-making by the relevant leadership organizations.
In the Fall of 2015, the WFWG proposed a formal workforce study to project supply of and demand for CGCs through 2026. The goal was to assemble the data required for the profession to take the necessary steps for ensuring consumer/patient access to the services CGCs provide. In the beginning of 2016 the WFWG, with the addition of the American Society of Human Genetics (ASHG), commissioned Dobson|DaVanzo, LLC to conduct a workforce analysis of CGCs in the United States. Dobson|DaVanzo is a Washington, D.C.-based health economics and policy consulting firm that had familiarity with the genetic counseling profession through previous work with NSGC.
Methods
Dobson|DaVanzo began the workforce study in December 2015. A comprehensive review of the literature, including both peer-reviewed and grey, was conducted to identify potential factors that may impact demand for CGC services. Other pertinent data that could inform the study was also collected, including data from the U.S Census Bureau on the expected rate of growth for the U.S. population between 2017 and 2026.
Eighteen interviews were conducted in March 2016 with individuals who had wide-ranging and detailed knowledge of the landscape of genetics and genomics and the roles played by CGCs. The individuals were identified by the WFWG based on their leadership in one or more of the following broad categories:
The interviews provided directional information for both Dobson|DaVanzo and the WFWG to use to inform the supply and a demand models for certified genetic counselors through 2026.
Throughout the process, the WFWG communicated regularly with Dobson|DaVanzo and provided guidance regarding interviewees and additional sources of data and validated or corrected assumptions. The WFWG also served as a sounding board for the supply and demand models being developed.
Supply Model
The supply model was developed using ABGC certification data, the NSGC Professional Status Survey (PSS), historical growth rates and projected attrition out of the profession. In addition, training program data were provided by AGCPD, including current and projected graduation rates from training programs, clinical rotation site capacity, and data on new training program applications to ACGC. The supply model also considered the distribution of CGC roles across the profession (e.g., direct patient care, industry, research) and the compound annual growth rate using the broad categories outlined above.
The projected supply of the CGC workforce from 2017 to 2026 was calculated using the following framework:
New entrants of CGC in year B Y^-Attrition in year B YÂ ttrition refers to CGCs who leave the workforce for any reason, such as retirement or change of profession. Using a model from the extant literature established for physical therapists, and applying the model to the age distribution information from the 2016 NSGC PSS, it was assumed that 85% of CGC professionals aged 55 years and older will retire over the next 10 years, and 14.3% of the professionals under 55 will leave the profession over the same period.
The following assumptions, based on the expert opinions of the WFWG, were made in order to calculate new entrants into the genetic counselor profession and the subsequent attrition rate:
Assumption-I: There will be approximately seven new training programs in 2015 and 2016. Four new programs will begin in 2017, and three new programs will begin in 2018 according to the ACGC. Assumption-II: Average annual matriculating class size of these new programs will be eight over the forecasted time period. Assumption-III: From 2021 to 2026, the graduation growth rates for existing programs and new programs will be constrained so that the 10-year compound annual growth rate (CAGR) will be 7.2%, thus the overall supply will roughly double from 2017 to 2026. Assumption-IV: To take into account the limited capacity of clinical sites, the growth rate of graduation for 2021-2026 is limited to 90% of the anticipated growth rate according to AGCPD and ACGC. Assumption-V: 95% of all graduates of accredited programs will continue to receive professional certification, as is the case currently, according to ABGC.
The supply of overall CGCs was calculated, along with the number of CGCs working in four major job categories: direct patient care, research/public health, education and industry. Distribution of CGCs among these four categories was calculated using data from the 2016 NSGC PSS. Projections for job category distribution through 2026 were made based on PSS trend and other data provided by the WFWG, literature review and anecdotal reports. It was estimated that in 2016, 65% of CGCs were working in direct patient care, and by 2026, 60% would work in direct patient care. The decision was made to focus the supply model on CGCs in direct patient care because the largest proportion of CGCs work in direct patient care and because the data were less clear regarding the future demand for CGCs in other jobs categories.
Demand Model
Developing the demand model for CGCs in direct patient care settings proved difficult because of the absence of U.S. data or guidelines indicating an appropriate ratio of CGCs per population and the many variables, known and unknown, that affect demand. These include awareness, referral patterns, reimbursement, geographic location and the potential availability of genetic tests in the future that may increase demand significantly. The demand model for CGCs employed outside of patient care was even more challenging due to the uncertainty about the job market in these settings. For these reasons, and because we restricted the supply model to CGCs employed in direct patient care, we focused the demand model on CGCs in direct patient care.
As a substitute for the lack of U.S. data on the appropriate population ratio of CGCs, we relied on data from the U.K.-based Association of Genetic Nurses and Counsellors (AGNC), which recommends one full-time equivalent (FTE) genetic counselor per 100,000 population (Association of Genetic Nurse and Counsellors 2016). A similar rate of one FTE genetic counselor per 75,000 covered lives has, anecdotally, been attributed to a large U.S. health system. Both rates represent services provided by genetic counselors providing services in direct patient care. Of note, for the purposes of this model these rates remained constant through the 10-year period.
Using these two demand scenarios 1) FTE genetic counselor per 100,000: scenario 1, 1 FTE genetic counselor per 75,000: scenario 2) and Census Bureau population data for the U.S., the number of genetic counselors required to meet demand in direct a patient care setting was calculated for each year through 2026. The anticipated supply of CGCs in direct patient care per year through 2026 was compared to the number of genetic counselors required to meet the demand under scenarios 1 and 2.
Results
The data in Table 1 indicate a shortage of genetic counselors engaged in direct patient care. Scenario 1 shows that between 2023 and 2024 the number of CGCs in direct patient care will satisfy a one FTE per 100,000 population demand. In Scenario 2 the shortage of CGCs in direct patient care will persist until 2030, at which time it will satisfy a one FTE per 75,000 population ratio.
Discussion
The purpose of the workforce study was to project supply of and demand for CGCs for the time period 2017 through 2026 with the goal of providing the data needed for the genetic counselor profession to take appropriate actions to ensure consumer/ patient access to the services genetic counselors provide.
Growth assumptions were built into the supply model, but already there are indications that the projected growth may have been underestimated. The model was based on the estimation of 14 new genetic counseling training programs established by 2018 with no new training programs established after 2018. However, given the rate of growth in programs in the six months since the study was completed, it is reasonable to expect that the number of new programs may be higher than anticipated by 2026. If true, and assuming that the additional growth in programs beyond the estimates used in the supply model is matched by equivalent growth in clinical training slots, the supply of CGCs in direct patient care would meet demand earlier than these models predict.
Limitations
There are several limitations of this study. Because of uncertainties surrounding both the supply of and demand for CGCs, a number of assumptions were made regarding the number of new genetic counseling training programs, growth in the size of existing training programs and graduation growth rates from those programs. In addition, several factors could influence the supply of and demand for CGCs that could not be easily quantified, and as a result, were not taken into account. These include, but are not limited to, the impact of the rapidly changing healthcare environment, coverage and reimbursement for CGC services, changes in the rate of integration of genomics into medicine, the introduction of genetic tests with high uptake, the substitution effect (i.e., use of non-genetics healthcare providers to meet patient needs), changes to payer coverage, and changes in the real or perceived clinical utility of genetic tests and genetic counselors.
Despite these limitations, this study has provided a clearer picture of the shortage of CGCs in what is currently the largest practice area, direct patient care. In addition, the results provide a framework for ongoing evaluation of policies and strategies that might be implemented to address the workforce shortage.
Conclusion
This study provides data and context for the next steps of the WFWG's efforts. Some of the work may involve:
& Conducting additional research to assess whether the assumptions of one FTE CGC per 100,000 or one per 75,000 population are indeed appropriate to meet current or future demand in the clinical setting in the U.S. & Expanding existing training programs and developing new programs. Activities around this initiative will be focused on accelerating growth, while being mindful of not overreaching and exceeding demand. & Exploring factors that create a Bsubstitution effect^(i.e., other healthcare providers providing genetic counseling to patients) and how that impacts quality of care, patient outcomes, and demand for CGC services. Leaders within the organizations represented in the WFWG are committed to developing these and additional strategies that will address the workforce challenges in the future. Since the completion of the workforce study, the WFWG has identified three priority areas (genetic counselor training, clinical supervisor recruitment, and health system and societal integration and awareness) to address over the next 36 months. A summit was held in Chicago on February 1, 2017 with leaders from all representative organizations to outline specific strategic goals, outcomes and action steps for each priority area. The strategic initiatives that emerged, complemented by ongoing collaboration with both public and private entities, will ensure a robust supply of CGCs to meet the exciting challenge of the future of genomic medicine.
